“Having the opportunity to be part of a team bringing innovative treatments to cancer patients continues to motivate me time and time again. The close interaction with leaders in the field is an honor and a pleasure.”
- Julia Schüler, DVM, PhD
Julia Schüler, PhD, studied veterinary medicine at the Freie Unversität Berlin (Germany) and at the Tierspital Zürich (Switzerland), where she received her DVM. She then joined the lab of Prof. Dr. Heiner Fiebig, founder of Oncotest GmbH, where she worked on orthotopic implantation of solid cancer PDX in immunocompromized mice.
After receiving her PhD from the University of Berlin, Dr. Schüler worked in the field of innate immunology at the Max-Planck Institute for Immunobiology, Freiburg, in the group of Dr. Marinus Lamers and Dr. Thomas Böhm, focusing on Toll-like receptor signaling. She later re-joined Oncotest, holding leadership positions in in vivo contract research as well as R&D.
Julia is particularly interested in modeling tumor biology, the tumor microenvironment, hematological malignancies, translational biomarker research, immuno-oncology and discovery platform development.
- CRISPR's Rogue Tendencies (Eureka)
- The Human Parts of Mouse Models (Contract Pharma)
- Knock-Out Punch in Breast Cancer Mouse Study (Eureka Blog)
- Translating Science into Survival (Eureka Blog)